載入...
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
BACKGROUND: With advent of direct-acting antiviral agents (DAA), hepatitis C virus (HCV) treatment is dramatically increasing. Although few studies reported rates of hepatocellular carcinoma (HCC) recurrence following DAA treatment, there have been no studies that followed sufficient number of DAA-t...
Na minha lista:
| 發表在: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819241/ https://ncbi.nlm.nih.gov/pubmed/31041639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-019-05641-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|